This might reflect on GSK/THRX relovair as it also has a qd LABA component (vilanterol trifenatate).
Do you consider the high dose of QAB149 DoA? The five positive panel votes and the lack of an actual safety signal makes me unsure what the FDA will do.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”